Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, making it valuable in drug discovery for targeted therapies. Also utilized in research settings to design compounds with improved metabolic stability and selectivity due to the presence of trifluoromethyl and methoxy groups. Shows potential in creating analogs for central nervous system drugs owing to its ability to cross the blood-brain barrier.